Literature DB >> 9035162

Persistent hypercalciuria and elevated 25-hydroxyvitamin D3 in children with infantile hypercalcaemia.

E Pronicka1, E Rowińska, H Kulczycka, J Lukaszkiewicz, R Lorenc, R Janas.   

Abstract

The aim of the study was to characterize abnormalities of calcium-phosphate and vitamin D3 metabolism in children with a past history of "mild" Lightwood-type idiopathic infantile hypercalcaemia. Seventeen seemingly healthy children aged 2-12 years, with long-term idiopathic hypercalcaemic syndrome since infancy were studied. Two reference groups were also included (vitamin D3 intoxication/healthy and Williams groups). Despite a long-term milk-restricted diet and a restricted vitamin D3 intake, urinary calcium excretion in the study group was 0.117 +/- 0.07 mumol/kg per 24 h. Compared with the reference groups (0.047 +/- 0.029 and 0.067 +/- 0.06 mumol/kg per 24 h, P < 0.05), there was significant hypercalciuria in the children with idiopathic hypercalcaemia since infancy. Serum concentrations of 25-hydroxyvitamin D3 in the study group were also elevated compared with the reference groups (57.4 +/- 15.5 vs. 34.6 +/- 9.3 and 22.7 +/- 10.5 ng/ml). 1,25-Dihydroxyvitamin D3 levels were at the upper limit of normal (45.9 +/- 13.1 vs. 35.0 +/- 8.1 and 30.0 +/- 13.7 pg/ml). Non-progressive, clinically silent nephrocalcinosis was visible on ultrasound examinations. The disturbances of vitamin D3 and calcium-phosphate metabolism persistent in the normocalcaemic phase of idiopathic infantile hypercalcaemia may be a primary metabolic defect of the condition. The mechanisms leading to elevation of metabolites of 1,25-dihydroxy- and 25-hydroxyvitamin D3 and the relationship between this and persistent hypercalciuria and nephrocalcinosis need pathophysiological explanation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9035162     DOI: 10.1007/s004670050221

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Long-term follow-up of patients with idiopathic infantile hypercalcaemia.

Authors:  Jianping Huang; David Coman; Steven J McTaggart; John R Burke
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

2.  Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia.

Authors:  Andrew Dauber; Thutrang T Nguyen; Etienne Sochett; David E C Cole; Ronald Horst; Steven A Abrams; Thomas O Carpenter; Joel N Hirschhorn
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

Review 3.  Not enough vitamin D: health consequences for Canadians.

Authors:  Gerry Schwalfenberg
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

4.  Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.

Authors:  Filip Fencl; Květa Bláhová; Karl Peter Schlingmann; Martin Konrad; Tomáš Seeman
Journal:  Eur J Pediatr       Date:  2012-09-22       Impact factor: 3.183

5.  Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.

Authors:  Ewa Pronicka; Elżbieta Ciara; Paulina Halat; Agnieszka Janiec; Marek Wójcik; Elżbieta Rowińska; Dariusz Rokicki; Paweł Płudowski; Ewa Wojciechowska; Aldona Wierzbicka; Janusz B Książyk; Agnieszka Jacoszek; Martin Konrad; Karl P Schlingmann; Mieczysław Litwin
Journal:  J Appl Genet       Date:  2017-05-03       Impact factor: 3.240

6.  25(OH)D Concentration in Neonates, Infants, and Toddlers From Poland-Evaluation of Trends During Years 1981-2011.

Authors:  Marek Wójcik; Maciej Jaworski; Pawel Pludowski
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-08       Impact factor: 5.555

7.  Vitamin D and Diseases of Mineral Homeostasis: A Cyp24a1 R396W Humanized Preclinical Model of Infantile Hypercalcemia Type 1.

Authors:  René St-Arnaud; Alice Arabian; Dila Kavame; Martin Kaufmann; Glenville Jones
Journal:  Nutrients       Date:  2022-08-06       Impact factor: 6.706

8.  Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study.

Authors:  Nina Lenherr-Taube; Michelle Furman; Esther Assor; Yesmino Elia; Carol Collins; Kenneth Thummel; Michael A Levine; Etienne Sochett
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

Review 9.  Genetic causes of neonatal and infantile hypercalcaemia.

Authors:  Caroline M Gorvin
Journal:  Pediatr Nephrol       Date:  2021-05-14       Impact factor: 3.714

10.  Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations.

Authors:  Agnieszka Janiec; Paulina Halat-Wolska; Łukasz Obrycki; Elżbieta Ciara; Marek Wójcik; Paweł Płudowski; Aldona Wierzbicka; Ewa Kowalska; Janusz B Książyk; Zbigniew Kułaga; Ewa Pronicka; Mieczysław Litwin
Journal:  Nephrol Dial Transplant       Date:  2021-07-23       Impact factor: 5.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.